Medgend Icon

Ledgend of Medicine







discontinued


Program

As a patient, you have certain rights. Some are guaranteed by federal law, such as the right to get a copy of your medical records, and the right to keep them private. Many states have additional laws protecting patients, and health care facilities often have a patient bill of rights.

An important patient right is informed consent. This means that if you need a treatment, your health care provider must give you the information you need to make a decision.

Many hospitals have patient advocates who can help you if you have problems. Many states have an ombudsman office for problems with long term care. Your state's department of health may also be able to help.

Program FDA Approved Drugs

ENDOMETRIN [ProgesteroneC21H30O2]
RX
-
100mg (vaginal insert)
FerringJun 21, 2007
  • Endometrin is a progesterone indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an assisted reproductive technology (art) treatment program for infertile women.
  • Support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an assisted reproductive technology (art) treatment program for infertile women.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

THALOMID [ThalidomideC13H10N2O4]
RX
-
100mg (oral capsule)
150mg (oral capsule)
200mg (oral capsule)
CelgeneJan 17, 2003
  • Acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (enl).
  • Approval for marketing only under a special restriction program approved by fda called 'system for thalidomide education and prescribing safety' (s.t.e.p.s.).
  • Maintenance therapy for prevention and supression of the cutaneous manifestations of enl recurrence.
  • Method for delivering a drug to a patient in need of the drug, while avoiding the occurence of an adverse side effect known or suspected of being caused by said drug.
  • Treatment of cutaneous manifestations of erythema nodosum leprosum (enl) in connection with a special program approved by fda called 'system for thalidomide education and prescribing safety' (s.t.e.p.s.).
  • Treatment of male patient having a disease or condition responsive to a teratogenic drug.
  • Use in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma.
  • Use of thalidomide in combination with dexamethasone for the treatment of patients with newly diagnosed multiple myeloma.
  • Use of thalidomide in treatment of cutaneous manifestations of erythema nodosum leprosum (enl).
  • Use of thalidomide while preventing the exposure of a fetus or other contraindicated individual to thalidomide.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.